This project provides medication and treatment for a Russian child with aplastic anemia. Aplastic anemia is a rare autoimmune disorder, but has excellent survival rates with treatment.
Children suffering from leukemia and aplastic anemia (a rare autoimmune disorder that renders the body unable to produce new blood cells) receive medical care at RCCH, the only hospital in Russia equipped to treat these diseases. A bone marrow transplant is one treatment option for patients of both leukemia and aplastic anemia; however, government funding for such transplants has been cut significantly in the past 10 years.
This project provides treatment for a ward of the Russian Central Children’s Hospital in Moscow. Children living on the ward require either a bone marrow transplant or immunosuppressant therapy-- two difficult yet highly successful treatment options.
The long-term goal of the program is to increase the number of children who receive life-saving bone marrow transplants as opposed to palliative treatment. This is possible through increases in program funding.
This project has provided additional documentation in a Microsoft Word file (projdoc.doc).
Research Institute for Pediatric Hematology
Korpus # 2, Komnata 208, Moscow - Russia
Director, Institute for Pediatric Hematology
Korpus # 2, Komnata 208,